Prediction of thrombosis in post-polycythemia vera and post-essential thrombocythemia myelofibrosis: a study on 1258 patients-Reference-Cited by-同舟云学术

Prediction of thrombosis in post-polycythemia vera and post-essential thrombocythemia myelofibrosis: a study on 1258 patients

Published:2022-08-30 Issue:10 Volume:36 Page:2453-2460
ISSN:0887-6924
Container-title:Leukemia
language:en
Short-container-title:Leukemia

Author:

Mora Barbara,Guglielmelli Paola^ORCID,Kuykendall Andrew,Rumi Elisa^ORCID,Maffioli Margherita,Palandri Francesca^ORCID,De Stefano Valerio^ORCID,Caramella Marianna,Salmoiraghi Silvia,Kiladjian Jean-Jacques,Gotlib Jason,Iurlo Alessandra^ORCID,Cervantes Francisco^ORCID,Ruggeri Marco,Silver Richard T.^ORCID,Albano Francesco^ORCID,Benevolo Giulia,Ross David M.^ORCID,Della Porta Matteo G.,Devos Timothy^ORCID,Rotunno Giada,Komrokji Rami S.^ORCID,Casetti Ilaria C.,Merli Michele^ORCID,Brociner Marco,Caramazza Domenica,Auteri Giuseppe,Barbui Tiziano^ORCID,Cattaneo Daniele,Bertù Lorenza,Arcaini Luca,Vannucchi Alessandro M.,Passamonti Francesco^ORCID

Publisher

Springer Science and Business Media LLC

Subject

Oncology,Cancer Research,Hematology

Link

https://www.nature.com/articles/s41375-022-01673-3.pdf

Reference60 articles.

1. Arber DA, Orazi A, Hasserjian R, Thiele J, Borowitz MJ, Le Beau MM, et al. The 2016 revision to the World Health Organization classification of myeloid neoplasms and acute leukemia. Blood. 2016;127:2391–405.

2. O’Shea JJ, Schwartz DM, Villarino AV, Gadina M, MCInnes IB, Laurence A. The JAK-STAT pathway: impact on human disease and therapeutic intervention. Annu Rev Med. 2015;66:311–28.

3. Geyer HL, Scherber RM, Dueck AC, Kiladjian J-J, Xiao Z, Slot S, et al. Distinct clustering of symptomatic burden among myeloproliferative neoplasm patients: retrospective assessment in 1470 patients. Blood. 2014;123:3803–10.

4. Guglielmelli P, Pacilli A, Rotunno G, Rumi E, Rosti V, Delaini F, et al. Presentation and outcome of patients with 2016 WHO diagnosis of prefibrotic and overt primary myelofibrosis. Blood. 2017;129:3227–36.

5. Barosi G, Mesa RA, Thiele J, Cervantes F, Campbell PJ, Versovsek S, et al. Proposed criteria for the diagnosis of post-polycythemia vera and post-essential thrombocythemia myelofibrosis: a consensus statement from the International Working Group for Myelofibrosis Research and Treatment. Leukemia. 2008;22:437–8.

Cited by 13 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Impact of somatic gene mutations on the risk of thrombosis in myelofibrosis;Leukemia;2024-08-30

2. Epidemiology and disease characteristics of myelofibrosis: a comparative analysis between Italy and global perspectives;Frontiers in Oncology;2024-07-24

3. Prediction of acute coronary syndrome in patients with myeloproliferative neoplasms;Frontiers in Cardiovascular Medicine;2024-06-25

4. Assessing haematological parameters and probable toxicity analysis in two coastal fish species at harbouring areas of Digha coastal belt, West Bengal, India;Environmental Research;2024-05

5. ADAMTS13, von Willebrand Factor, Platelet Microparticles, Factor VIII, and Impact of Somatic Mutations in the Pathogenesis of Splanchnic Vein Thrombosis Associated with BCR-ABL-Negative Myeloproliferative Neoplasms;Life;2024-04-09